Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Sales | 3,616,700 | 3,489,800 | 3,526,300 | 3,439,000 | 3,356,500 |
| Cost of Goods | 476,300 | 602,000 | 488,500 | 460,800 | 421,000 |
| Gross Profit | 3,140,400 | 2,887,800 | 3,037,800 | 2,978,200 | 2,935,500 |
| Operating Expenses | 1,184,800 | 1,385,100 | 1,595,199 | 1,281,400 | 1,722,300 |
| Operating Income | 1,955,900 | 1,502,700 | 1,443,100 | 1,697,600 | 1,213,200 |
| Other Income | -213,700 | 328,600 | -28,600 | 115,100 | -34,500 |
| Pre-tax Income | 1,742,200 | 1,831,300 | 1,414,500 | 1,812,700 | 1,178,700 |
| Income Tax | 248,100 | 422,500 | 469,600 | 369,800 | 263,700 |
| Net Income Continuous | 1,494,100 | 1,408,800 | 944,900 | 1,442,900 | 915,000 |
| Minority Interests | N/A | N/A | -1,900 | -1,500 | 48,400 |
| Net Income | $1,494,100 | $1,408,800 | $946,800 | $1,444,400 | $866,600 |
| EPS Basic Total Ops | 7.85 | 7.17 | 4.73 | 7.17 | 4.18 |
| EPS Basic Continuous Ops | 7.85 | 7.17 | 4.71 | 7.16 | 4.42 |
| EPS Diluted Total Ops | 7.85 | 7.15 | 4.71 | 7.15 | 4.18 |
| EPS Diluted Continuous Ops | 7.85 | 7.15 | 4.70 | 7.15 | 4.41 |
| EBITDA(a) | $2,072,900 | $1,623,800 | $1,406,701 | $2,044,100 | $1,384,700 |